| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
NEUROLOGY 1986;36:466-470
© 1986 American Academy of Neurology
ARTICLES |
ST Chen, CY Hsu, EL Hogan, PV Halushka, OI Linet and FM Yatsu
Our understanding of the biochemistry and biologic actions of AA metabolites has been greatly expanded in recent years. The discoveries of TXA2, PGI2, and LTs have fostered new concepts of the pathophysiology of cerebral ischemia. New approaches to treatment of ischemia include seeking an optimal dose of aspirin, developing drugs that selectively inhibit or antagonize TXA2 or LTs, and administering PGI2 or its analogues. Altering the dietary content of essential fatty acids for prophylaxis is also being studied. Though the results of this thrust are still preliminary, the exploration of these therapeutic strategies in cerebrovascular disorders based on further understanding of the pathophysiologic roles of TXA2, PGI2, LTs and probably other AA metabolites is anticipated with some optimism.
This article has been cited by other articles:
|
|
 |
|
  J. D. Schmoker, C. Terrien III, K. J. McPartland, J. Boyum, G. C. Wellman, L. Trombley, and J. Kinne Cerebrovascular response to continuous cold perfusion and hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 459 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I-S. Yu, S.-R. Lin, C.-C. Huang, H.-Y. Tseng, P.-H. Huang, G.-Y. Shi, H.-L. Wu, C.-L. Tang, P.-H. Chu, L.-H. Wang, et al. TXAS-deleted mice exhibit normal thrombopoiesis, defective hemostasis, and resistance to arachidonate-induced death Blood, July 1, 2004; 104(1): 135 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sanchez-Moreno, J. F. Dashe, T. Scott, D. Thaler, M. F. Folstein, and A. Martin Decreased Levels of Plasma Vitamin C and Increased Concentrations of Inflammatory and Oxidative Stress Markers After Stroke Stroke, January 1, 2004; 35(1): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rungger–Brändle, A. A. Dosso, and P. M. Leuenberger Glial Reactivity, an Early Feature of Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1971 - 1980. [Abstract] [Full Text]
|
|
|
|
|
|
J. Koistinaho, S. Koponen, P. H. Chan, and C. Y. Hsu Expression of Cyclooxygenase-2 mRNA After Global Ischemia Is Regulated by AMPA Receptors and Glucocorticoids • Editorial Comment Stroke, September 1, 1999; 30(9): 1900 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tong, E. Richards, and C. E. Wood Prostaglandin Endoperoxide Synthase-2 Abundance Is Increased in Brain Tissues of Late-Gestation Fetal Sheep in Response to Cerebral Hypoperfusion Reproductive Sciences, May 1, 1999; 6(3): 127 - 135. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Janabi, I. Hau, and M. Tardieu Negative Feedback Between Prostaglandin and {alpha}- and {beta}-Chemokine Synthesis in Human Microglial Cells and Astrocytes J. Immunol., February 1, 1999; 162(3): 1701 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lin, T.-N. Lin, W.-M. Cheung, G.-M. Nian, P.-H. Tseng, S.-F. Chen, J.-J. Chen, S.-K. Shyue, J.-Y. Liou, C.-W. Wu, et al. Cyclooxygenase-1 and Bicistronic Cyclooxygenase-1/Prostacyclin Synthase Gene Transfer Protect Against Ischemic Cerebral Infarction Circulation, April 23, 2002; 105(16): 1962 - 1969. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
